Champlain Investment Partners’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-893,908
Closed -$61.7M – 130
2024
Q1
$61.7M Sell
893,908
-1,023,225
-53% -$69M 0.35% 98
2023
Q4
$119M Sell
1,917,133
-96,268
-5% -$5.39M 0.71% 58
2023
Q3
$113M Buy
2,013,401
+272,006
+16% +$15.3M 0.73% 56
2023
Q2
$87.9M Buy
1,741,395
+404,550
+30% +$21.5M 0.54% 80
2023
Q1
$72.9M Buy
1,336,845
+249,595
+23% +$14.6M 0.46% 90
2022
Q4
$68M Buy
1,087,250
+204,660
+23% +$13.6M 0.44% 94
2022
Q3
$62.2M Sell
882,590
-209,005
-19% -$14.4M 0.42% 96
2022
Q2
$61.9M Buy
1,091,595
+97,760
+10% +$5.36M 0.4% 100
2022
Q1
$62.2M Buy
993,835
+291,045
+41% +$15.7M 0.32% 107
2021
Q4
$39.4M Buy
702,790
+374,160
+114% +$22.9M 0.18% 127
2021
Q3
$21.4M Buy
+328,630
New +$22.4M 0.1% 133

Other funds holding AXNX

Champlain Investment Partners's AXNX Position: Q2 2024 in Review

Champlain Investment Partners sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2024, closing a stake of 893,908 shares — an estimated $61.7M sold.

Champlain Investment Partners first reported a position in AXNX in Q3 2021 and held it in 11 quarters. The position peaked at $119M in Q4 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2024.

  • Champlain Investment Partners reported no remaining Axonics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Champlain Investment Partners sold 893,908 Axonics, Inc. Common Stock shares in Q2 2024, an estimated $61.7M.
  • Champlain Investment Partners first reported a position in Axonics, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Champlain Investment Partners's Axonics, Inc. Common Stock position peaked at $119M in Q4 2023.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2024.

Based on Champlain Investment Partners's 13F filing for Q2 2024, filed 14 Aug 2024.